These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4703 related articles for article (PubMed ID: 6159628)

  • 21. Shark cartilage contains inhibitors of tumor angiogenesis.
    Lee A; Langer R
    Science; 1983 Sep; 221(4616):1185-7. PubMed ID: 6193581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.
    Keyes KA; Mann L; Cox K; Treadway P; Iversen P; Chen YF; Teicher BA
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):321-7. PubMed ID: 12721760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of tumor angiogenesis mediated by cartilage.
    Brem H; Folkman J
    J Exp Med; 1975 Feb; 141(2):427-39. PubMed ID: 1113064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK; Halsør EF
    Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
    Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
    Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
    Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
    Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Regulation of angiogenesis and tumor growth].
    Tseĭtlin DM
    Eksp Onkol; 1985; 7(1):10-4. PubMed ID: 2579791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-tumor injection of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX2 carcinoma of the tongue.
    Matsumoto K; Ninomiya Y; Inoue M; Tomioka T
    Int J Oral Maxillofac Surg; 1999 Apr; 28(2):118-24. PubMed ID: 10102393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological evaluation of a multi-targeted small molecule inhibitor of tumor-induced angiogenesis.
    McDermott LA; Higgins B; Simcox M; Luk KC; Nevins T; Kolinsky K; Smith M; Yang H; Li JK; Chen Y; Ke J; Mallalieu N; Egan T; Kolis S; Railkar A; Gerber L; Liu JJ; Konzelmann F; Zhang Z; Flynn T; Morales O; Chen Y
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1950-3. PubMed ID: 16460940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen.
    Bouquet C; Lamandé N; Brand M; Gasc JM; Jullienne B; Faure G; Griscelli F; Opolon P; Connault E; Perricaudet M; Corvol P
    Mol Ther; 2006 Aug; 14(2):175-82. PubMed ID: 16600689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral vector-mediated transduction of a modified thrombospondin-2 cDNA inhibits tumor growth and angiogenesis.
    Hahn W; Ho SH; Jeong JG; Hahn EY; Kim S; Yu SS; Kim S; Kim JM
    Gene Ther; 2004 May; 11(9):739-45. PubMed ID: 15103317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of growth and vascularity of B16 melanoma by syngeneic lymphocytes.
    Gersten DM
    Cell Biol Int Rep; 1980 Apr; 4(4):407-14. PubMed ID: 6156016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis.
    Yi M; Ruoslahti E
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):620-4. PubMed ID: 11209058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth.
    Egami K; Murohara T; Shimada T; Sasaki K; Shintani S; Sugaya T; Ishii M; Akagi T; Ikeda H; Matsuishi T; Imaizumi T
    J Clin Invest; 2003 Jul; 112(1):67-75. PubMed ID: 12840060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of tumor angiogenesis in an id mouse model: role of host-tumor interactions.
    Kreisle RA; Ershler WB
    J Natl Cancer Inst; 1988 Aug; 80(11):849-54. PubMed ID: 2455811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice.
    Aozuka Y; Koizumi K; Saitoh Y; Ueda Y; Sakurai H; Saiki I
    Cancer Lett; 2004 Dec; 216(1):35-42. PubMed ID: 15500947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.
    Beebe JS; Jani JP; Knauth E; Goodwin P; Higdon C; Rossi AM; Emerson E; Finkelstein M; Floyd E; Harriman S; Atherton J; Hillerman S; Soderstrom C; Kou K; Gant T; Noe MC; Foster B; Rastinejad F; Marx MA; Schaeffer T; Whalen PM; Roberts WG
    Cancer Res; 2003 Nov; 63(21):7301-9. PubMed ID: 14612527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
    Yuan F; Chen Y; Dellian M; Safabakhsh N; Ferrara N; Jain RK
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14765-70. PubMed ID: 8962129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-1 is required for tumor invasiveness and angiogenesis.
    Voronov E; Shouval DS; Krelin Y; Cagnano E; Benharroch D; Iwakura Y; Dinarello CA; Apte RN
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2645-50. PubMed ID: 12598651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 236.